Susannah O’Sullivan

705 total citations
18 papers, 458 citations indexed

About

Susannah O’Sullivan is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Hematology. According to data from OpenAlex, Susannah O’Sullivan has authored 18 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Hematology. Recurrent topics in Susannah O’Sullivan's work include Bone health and treatments (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Thyroid Disorders and Treatments (5 papers). Susannah O’Sullivan is often cited by papers focused on Bone health and treatments (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Thyroid Disorders and Treatments (5 papers). Susannah O’Sullivan collaborates with scholars based in New Zealand, Australia and Sweden. Susannah O’Sullivan's co-authors include Andrew Grey, Ian R. Reid, Ruma G. Singh, Karen E. Callon, Peter Browett, Anne Horne, D. Wattie, Dorit Naot, Maureen Watson and J. Cornish and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Susannah O’Sullivan

18 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susannah O’Sullivan New Zealand 10 226 145 111 107 69 18 458
Josephine T. Tauer Germany 12 79 0.3× 52 0.4× 244 2.2× 97 0.9× 81 1.2× 42 546
I Yamamoto Japan 10 215 1.0× 86 0.6× 110 1.0× 138 1.3× 13 0.2× 30 462
Gökhan Demir Türkiye 14 154 0.7× 20 0.1× 75 0.7× 72 0.7× 20 0.3× 69 555
Rebecca Pedersini Italy 15 306 1.4× 95 0.7× 15 0.1× 97 0.9× 11 0.2× 41 551
Hallie Zietz United States 10 158 0.7× 41 0.3× 28 0.3× 36 0.3× 49 0.7× 12 353
Edgardo Angtuaco United States 7 300 1.3× 37 0.3× 440 4.0× 246 2.3× 16 0.2× 14 645
Charles Zarnitsky France 8 75 0.3× 45 0.3× 29 0.3× 72 0.7× 35 0.5× 19 463
A. T. Reece United Kingdom 6 191 0.8× 23 0.2× 409 3.7× 166 1.6× 32 0.5× 9 545
Rasho Rashkov Bulgaria 12 66 0.3× 96 0.7× 47 0.4× 74 0.7× 13 0.2× 47 475
A Castello Italy 13 93 0.4× 60 0.4× 384 3.5× 92 0.9× 22 0.3× 32 594

Countries citing papers authored by Susannah O’Sullivan

Since Specialization
Citations

This map shows the geographic impact of Susannah O’Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susannah O’Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susannah O’Sullivan more than expected).

Fields of papers citing papers by Susannah O’Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susannah O’Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susannah O’Sullivan. The network helps show where Susannah O’Sullivan may publish in the future.

Co-authorship network of co-authors of Susannah O’Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Susannah O’Sullivan. A scholar is included among the top collaborators of Susannah O’Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susannah O’Sullivan. Susannah O’Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Johnson, Neil, et al.. (2024). Iodine and other factors associated with fertility outcome following oil-soluble contrast medium hysterosalpingography: a prospective cohort study. Frontiers in Endocrinology. 15. 1257888–1257888. 1 indexed citations
2.
O’Sullivan, Susannah, José G. B. Derraik, Natasha Heather, et al.. (2023). The impact of prolonged, maternal iodine exposure in early gestation on neonatal thyroid function. Frontiers in Endocrinology. 14. 1080330–1080330. 2 indexed citations
3.
Johnson, Neil P., et al.. (2022). The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography. The Journal of Clinical Endocrinology & Metabolism. 107(12). 3252–3260. 13 indexed citations
4.
Johnson, Neil P., et al.. (2022). Hysterosalpingography with Oil-Soluble Contrast Medium Does Not Increase Newborn Hypothyroidism. International Journal of Endocrinology. 2022. 1–7. 3 indexed citations
6.
Johnson, Neil, et al.. (2020). Iodine and fertility: do we know enough?. Human Reproduction. 36(2). 265–274. 17 indexed citations
7.
O’Sullivan, Susannah, et al.. (2019). An observational study of pregnancy and post‐partum outcomes in women with prolactinoma treated with dopamine agonists. Australian and New Zealand Journal of Obstetrics and Gynaecology. 60(3). 405–411. 13 indexed citations
8.
O’Sullivan, Susannah, Mei Lin Tay, Jianming Lin, et al.. (2016). Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. PLoS ONE. 11(10). e0164727–e0164727. 5 indexed citations
9.
O’Sullivan, Susannah & Andrew Grey. (2014). Adverse skeletal effects of drugs – beyond Glucocorticoids. Clinical Endocrinology. 82(1). 12–22. 7 indexed citations
10.
O’Sullivan, Susannah, et al.. (2013). Bone Density in Heart or Lung Transplant Recipients-A Longitudinal Study. Transplantation Proceedings. 45(6). 2357–2365. 35 indexed citations
11.
Milsom, Stella R., et al.. (2012). Treatment of infertility with hypogonadotropic hypogonadism: 10‐year experience in Auckland, New Zealand. Australian and New Zealand Journal of Obstetrics and Gynaecology. 52(3). 293–298. 9 indexed citations
12.
O’Sullivan, Susannah, Jianming Lin, Maureen Watson, et al.. (2011). The skeletal effects of the tyrosine kinase inhibitor nilotinib. Bone. 49(2). 281–289. 32 indexed citations
13.
O’Sullivan, Susannah & Andrew Grey. (2011). The skeletal effects of the tyrosine kinase inhibitor nilotinib. Bone. 49(5). 1119–1119. 1 indexed citations
14.
O’Sullivan, Susannah, Dorit Naot, Karen E. Callon, et al.. (2010). Imatinib Mesylate Does Not Increase Bone Volume In Vivo. Calcified Tissue International. 88(1). 16–22. 17 indexed citations
15.
Grey, Andrew, Claire Chaussade, Victoria Empson, et al.. (2009). Evidence for a role for the p110-α isoform of PI3K in skeletal function. Biochemical and Biophysical Research Communications. 391(1). 564–569. 10 indexed citations
16.
O’Sullivan, Susannah, Anne Horne, D. Wattie, et al.. (2009). Decreased Bone Turnover Despite Persistent Secondary Hyperparathyroidism during Prolonged Treatment with Imatinib. The Journal of Clinical Endocrinology & Metabolism. 94(4). 1131–1136. 54 indexed citations
17.
O’Sullivan, Susannah, Dorit Naot, Karen E. Callon, et al.. (2007). Imatinib Promotes Osteoblast Differentiation by Inhibiting PDGFR Signaling and Inhibits Osteoclastogenesis by Both Direct and Stromal Cell-Dependent Mechanisms. Journal of Bone and Mineral Research. 22(11). 1679–1689. 105 indexed citations
18.
O’Sullivan, Susannah, Andrew Grey, Ruma G. Singh, & Ian R. Reid. (2006). Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporosis International. 17(7). 1008–1012. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026